It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:

Southwestern Energy: "I like that one because I'm a believer in natural gas here because of all of its extra uses, and Cheniere 's Charif Souki was a visionary and still is."

Gilead Sciences: "Gilead right now is a don't buy. They've got to do an acquisition, they have no growth."

Cerner: "No, Cerner is in that kind of netherworld of medical. Right now the only one I am recommending is UnitedHealth, UNH."

Cemex: "No, I like US Concrete, USCR. Better buy, better balance sheet."

Bluebird Bio: "Bluebird Bio is a very good spec, but it is a spec. Remember, Celgene is the more conservative of the lot."

GlaxoSmithKline: "GlaxoSmithKline doesn't have growth. If we are going to buy a pharmaceutical we want growth, and the one that has the most is the one that my charitable trust, actionalertsplus.com owns, which is Allergan. Brent Saunders' [CEO] and nobody wants. Wait until January when the tax loss selling is over."

Corecivic: "We are worried about the private jails, we think they have moved up too much. We are going to stay away, but I do say that this one is a little cheaper than some of the others we have profiled."

Ashland: "People don't like Ashland, but I like it because it's international and people are backing away from it. It's very, very shareholder friendly."

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com